TREA

79378675 - NORDIC BIOSCIENCE

Follow

Information

  • Trademark
  • 79378675
  • Serial Number
    79378675
  • Filing Date
    July 19, 2023
    2 years ago
  • Transaction Date
    March 01, 2025
    10 months ago
  • Status Date
    November 05, 2024
    a year ago
  • Location Date
    November 05, 2024
    a year ago
  • Status Code
    661
  • Current Location
    TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    BIBB, SCOTT
  • Attorney Docket Number
    1478.0001
    Attorney Name
    Andrew M. Smith
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
3
Mark Identification
NORDIC BIOSCIENCE
Case File Statements
  • DM0000: The mark consists of an image of three stylized dots connected with lines, with a single dot to the right, all appearing to the left of the wording NORDIC BIOSCIENCE.
  • GS0051: diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use
  • TF0000: NORDIC has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
  • DS0000: BIOSCIENCE
  • GS0421: custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing
Case File Event Statements
  • 9/14/2023 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 9/15/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/19/2023 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/25/2024 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/2/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2024 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/3/2024 - a year ago
    7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR
  • 5/3/2024 - a year ago
    8 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/5/2024 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/5/2024 - a year ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/4/2024 - a year ago
    9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/10/2024 - a year ago
    11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/10/2024 - a year ago
    10 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/3/2024 - a year ago
    12 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/5/2024 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/12/2025 - 10 months ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/12/2025 - 10 months ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 3/1/2025 - 10 months ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX